Planning for Scale from the Start: Where Early Development Decisions Create Commercial Risk

November 9, 2026 | 11:00 AM ET

This webinar will explore how emerging biopharma companies can maintain streamlined clinical development and manufacturing strategies while establishing a strong foundation for commercialization earlier in development.

Through accelerated timelines and connected manufacturing planning, companies can prepare for future demand, reduce scale-up and technology transfer risk, strengthen cross-functional launch readiness, and build a resilient supply strategy as their programs progress.

Attendees will learn how to:

• Plan for commercial demand earlier by considering future scale, capacity, and supply requirements during development
• Reduce development-to-commercial transition risk through an accelerated, connected approach that limits scale-up and technology transfer complexity
• Strengthen launch readiness and supply resilience by aligning development, manufacturing, quality, and supply chain planning from the outset